Literature DB >> 24256292

Metacognitive therapy in recurrent depression: a case replication series in Denmark.

Pia Callesen1, Anne Backhausen Jensen, Adrian Wells.   

Abstract

Metacognitive therapy (MCT) for depression is derived from the Wells and Matthews (1994) self-regulatory model, in which a Cognitive-Attentional Syndrome (CAS) is the cause of psychological disorders. MCT for depression focuses on identifying patients' CAS and helps them to stop it. The CAS consists of worry, rumination and dysfunctional coping strategies. The focus in MCT is on removing the CAS by challenging positive and negative metacognitive beliefs and eliminating dysfunctional behaviors. In this case series, MCT was delivered to four depressed Danes and treatment was evaluated in 5-11 sessions of up to one hour each. An A-B design with follow-up at 3 and 6 months was conducted and the primary outcome was Beck's Depression Inventory II (BDI-II). We measured CAS processes with the Major depressive Disorder Scale (MDD-S). The results of the case series showed clinically significant improvements in depressive symptoms, rumination and metacognitive beliefs and the effects were still present at follow-up for all patients. The small number of patients and decreasing baselines observed in some cases limits the conclusions. However, the results suggest that this treatment is feasible and was associated with large improvements in symptoms when delivered away from its point of origin and in a Danish help-seeking sample.
© 2013 Scandinavian Psychological Associations and John Wiley & Sons Ltd.

Entities:  

Keywords:  Denmark; Metacognitive therapy; recurrent depression; single case study

Mesh:

Year:  2013        PMID: 24256292     DOI: 10.1111/sjop.12089

Source DB:  PubMed          Journal:  Scand J Psychol        ISSN: 0036-5564


  6 in total

1.  Metacognitive Therapy for Depression in Adults: A Waiting List Randomized Controlled Trial with Six Months Follow-Up.

Authors:  Roger Hagen; Odin Hjemdal; Stian Solem; Leif Edward Ottesen Kennair; Hans M Nordahl; Peter Fisher; Adrian Wells
Journal:  Front Psychol       Date:  2017-01-24

2.  PRO*MDD Study Protocol: Effectiveness of Outpatient Treatment Programs for Major Depressive Disorder: Metacognitive Therapy vs. Behavioral Activation a Single-Center Randomized Clinical Trial.

Authors:  Anja Schaich; Laura Heikaus; Nele Assmann; Sandra Köhne; Kamila Jauch-Chara; Michael Hüppe; Adrian Wells; Ulrich Schweiger; Jan Philipp Klein; Eva Fassbinder
Journal:  Front Psychiatry       Date:  2018-11-19       Impact factor: 4.157

3.  A Randomized Controlled Trial of Metacognitive Therapy for Depression: Analysis of 1-Year Follow-Up.

Authors:  Odin Hjemdal; Stian Solem; Roger Hagen; Leif Edward Ottesen Kennair; Hans M Nordahl; Adrian Wells
Journal:  Front Psychol       Date:  2019-08-08

4.  A Comparison of Metacognitive Therapy in Current Versus Persistent Depressive Disorder - A Pilot Outpatient Study.

Authors:  Lotta Winter; Julia Gottschalk; Janina Nielsen; Adrian Wells; Ulrich Schweiger; Kai G Kahl
Journal:  Front Psychol       Date:  2019-08-06

5.  Role of rumination in the relationship between metacognition and shyness.

Authors:  Sara Palmieri; Giovanni Mansueto; Simona Scaini; Francesca Fiore; Sandra Sassaroli; Giovanni M Ruggiero; Rosita Borlimi; Bernardo J Carducci
Journal:  World J Psychiatry       Date:  2018-10-14

6.  Citalopram and metacognitive therapy for depressive symptoms and cognitive emotion regulation in patients with major depressive disorder: A randomized controlled trial.

Authors:  Gholam Reza Kheirabadi; Zahra Yousefian; Fatemeh Zargar; Mahboobe Bahrami; Mohammad R Maracy
Journal:  J Educ Health Promot       Date:  2020-01-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.